Search Ontology:
ChEBI
camostat mesylate
- Term ID
- CHEBI:31347
- Synonyms
-
- 4-{2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl}phenyl 4-carbamimidamidobenzoate methanesulfonate
- amino{4-[(4-{2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl}phenoxy)carbonyl]anilino}methaniminium methanesulfonate
- camostat methanesulfonate
- camostat monomethanesulfonate
- Foipan
- Foistar
- FOY 305
- FOY-305
- FOY305
- N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)phenylacetate methanesulfate
- Definition
- A methanesulfonate (mesylate) salt prepared from equimolar amounts of camostat and methanesulfonic acid. It is a serine protease inhibitor approved and marketed in Japan in 1985 for the alleviation of acute symptoms associated with chronic pancreatitis. In 1994, it was approved for the treatment of postoperative reflux esophagitis.
- References
-
- CAS:59721-29-8
- Chemspider:39251
- DrugBank:DBSALT002914
- KEGG:D01766
- PMID:15796165
- PMID:16677167
- PMID:17433371
- PMID:1879802
- PMID:19876587
- PMID:20574618
- PMID:21528279
- PMID:21541544
- PMID:21590090
- PMID:2455235
- PMID:25345960
- PMID:25766432
- PMID:26887332
- PMID:27408783
- PMID:30391941
- PMID:32347443
- PMID:32696234
- PMID:33176395
- PMID:33225308
- PMID:33647240
- PMID:33676899
- PMID:6590712
- PMID:7341342
- PMID:8886041
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_part
-
- has_role
Phenotype
Phenotype resulting from camostat mesylate
Phenotype where environments contain camostat mesylate
Phenotype modified by environments containing camostat mesylate
Human Disease Model